Case Report
New-Onset Focal Nodular Hyperplasia in a Patient with Viral Hepatitis: A Case Report
Zhang Y1, Ding H1,2*, Peng SY1, Ji Y3 and Wang WP11Department of Ultrasound, Zhongshan Hospital, Shanghai Institute of Medical Imaging, Fudan University, Shanghai 200032, China
2Department of Ultrasound, Qingpu Branch of Zhongshan Hospital, Fudan University, Shanghai 201700, China
3Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai 200032, China
- Corresponding Author:
- Hong Ding
Department of Ultrasound, Zhongshan Hospital,
Shanghai Institute of Medical Imaging,
Fudan University, 180 Fenglin Road, Shanghai 200032, China
Tel: +86-136-5188-6013
E-mail: ding.hong@zs-hospital.sh.cn
Received Date: October 24, 2016; Accepted Date: November 15, 2016; Published Date: November 18, 2016
Citation: Zhang Y, Ding H, Peng SY, Ji Y, Wang WP (2016) New-Onset Focal Nodular Hyperplasia in a Patient with Viral Hepatitis: A Case Report. OMICS J Radiol 5:239. doi: 10.4172/2167-7964.1000239
Copyright: © 2016 Zhang Y, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Background: New-onset hepatic nodules mostly are hepatocellular carcinomas in patients with viral hepatitis. Focal Nodular Hyperplasia (FNH) is the second most common benign liver tumor, which usually does not recur after surgical resection. We present a case of hepatitis B virus infected female with a new-onset FNH during pregnancy, which has not been reported before, to not only put an emphasis on the diagnostic accuracy of FNH but also avoid unnecessary surgical intervention. Case presentation: The 28-year-old Chinese female with chronic hepatitis B virus infection who underwent a resection of FNH in the left lobe of the liver three years ago, was found to present with a new-onset solid lesion in the right lobe of the liver. Contrast-Enhanced Ultrasound (CEUS) demonstrated a typical FNH of spoke wheel pattern enhancement in the arterial phase, still enhanced during the portal venous and delayed phases with a central stellate scar, which showed a similar enhancement pattern on contrast-enhanced CT and MRI. Finally, a core needle biopsy of the suspected lesion was confirmed to be FNH. Conclusion: Regenerate of FNH may also occur in patients with chronic hepatitis B, which was known as a risk factor for the occurrence of hepatocellular carcinoma. Diagnosis of FNH can be made definitely and non-invasively through the appliance of modern imaging modalities with typical performance of imaging features.
